NCT04273763: Evaluating the Efficacy and Safety of Bromhexine Hydrochloride Tablets Combined With Standard Treatment/ Standard Treatment in Patients With Suspected and Mild Novel Coronavirus Pneumonia (COVID-19) |
|
|
| Unknown status | N/A | 18 | RoW | Bromhexine Hydrochloride Tablets, Arbidol Hydrochloride Granules, Recombinant Human Interferon α2b Spray | Second Affiliated Hospital of Wenzhou Medical University, Wanbangde Pharmaceutical Group Co., LTD | Novel Coronavirus Pneumonia, 2019-nCoV | 05/20 | 06/20 | | |
ChiCTR2200058790: Prospective, randomized controlled clinical study on the efficacy and safety of human interferon α2b spray in the treatment of asymptomatic patients infected with novel coronavirus Omicron variant |
|
|
| Recruiting | N/A | 400 | | Add topical spraying of human interferon α2b solution in the nose and oropharynx to the basic and herbal treatment ;Centralized isolation management, bed rest, application of traditional Chinese medicine, strengthening supportive treatment, ensuring adequate energy and nutrition intake; paying attention to water and electrolyte balance, maintaining a stable internal environment, and closely monitoring vital signs and clinical symptoms. | The First Affiliated Hospital of Anhui Medical University; The First Affiliated Hospital of Anhui Medical University, Anhui Anke Biological Engineering (Group) Co. | Asymptomatic patients infected with a novel coronavirus Omicron variant | | | | |
